Colorado's pioneering cannabis market just got a report card, and testing was the weak subject.
A new state audit of the Marijuana Enforcement Division (MED), presented to lawmakers on the Legislative Audit Committee on Monday, found significant gaps in how products are tested and monitored. "There's an increased risk that marijuana products sold in Colorado may have contaminants or may inaccurately list potency," audit supervisor Catherine Friday told the committee.
A big issue: Colorado businesses pick their own samples to send to private labs. According to the report, 24 other legal states don't allow that and rely on a third party instead. Auditors also found that from 2023 to 2025, potentially harmful products stayed on the market for more than seven months on average before the state issued an advisory, though that timeline improved in 2025 after guidelines were revised.
The good news: auditors did not find evidence of widespread health and safety risks. The division agreed with all of the recommendations, and lawmakers could consider a bill next session to boost the state reference lab, which officials say would need about $13 million to expand its testing.
This follows the hearing we flagged on Oct. 18.
What it means for travelers: Colorado is still a great place to shop legally. Buy only from licensed dispensaries, keep your receipt, and check the state's health and safety advisories if a product seems off.






